Association between the COVID-19 Vaccine and Preventive Behaviors: Panel Data Analysis from Japan
Abstract
:1. Introduction
2. Materials and Methods
2.1. Data Collection
2.2. Ethical Considerations
2.3. Measurements
- (1)
- Staying indoors.
- (2)
- Not going out to the workplace (or school).
- (3)
- Not going out to events or travel.
- (4)
- Washing my hands thoroughly.
- (5)
- Wearing a mask.
2.4. Methods
α5 VACCINE SECOND_4it + α6 PROB COVID19it + α7 SEVERITY COVID19 it +α8 EMERGENCY it + kt + mi + uitg,
3. Results
Variables | Mean | s.d. |
---|---|---|
STAYING INDOORS | 2.91 | 1.25 |
NOT GOING TO WORK | 2.94 | 1.73 |
NOT FOR LEISURE | 4.12 | 1.18 |
HANDWASHING | 4.14 | 0.95 |
WEARING MASK | 4.41 | 1.05 |
VACCINE FIRST | 0.03 | 0.17 |
VACCINE SECOND | 0.06 | 0.24 |
VACCINE SECOND_1 | 0.03 | 0.18 |
VACCINE SECOND_2 | 0.02 | 0.14 |
VACCINE SECOND_3 | 0.01 | 0.08 |
VACCINE SECOND_4 | 0.001 | 0.04 |
PROB_COVID19 | 20.4 | 22.3 |
SEVERITY COVID19 | 3.57 | 1.21 |
EMERGENCY | 0.29 | 0.45 |
FEAR | 3.06 | 1.14 |
ANXIETY | 3.28 | 1.15 |
ANGER | 2.98 | 1.10 |
AGE | 48.7 | 17.3 |
MALE | 0.50 | 0.50 |
UNIVERSITY | 0.43 | 0.49 |
Waves | Dates | All % | Age > 40 % | Age ≤ 40 % |
---|---|---|---|---|
1 | 13–16 March 2020 | 0 | 0 | 0 |
2 | 27–30 March 2020 | 0 | 0 | 0 |
3 | 10–13 April 2020 | 0 | 0 | 0 |
4 | 8–11 May 2020 | 0 | 0 | 0 |
5 | 12–15 June 2020 | 0 | 0 | 0 |
6 | 23–28 October 2020 | 0 | 0 | 0 |
7 | 4–8 December 2020 | 0 | 0 | 0 |
8 | 15–19 January 2021 | 0 | 0 | 0 |
9 | 17–22 February 2021 | 0 | 0 | 0 |
10 | 24–29 March 2021 | 0 | 0 | 0 |
11 | 23–26 April 2021 | 0 | 0 | 0 |
12 | 28–31 May 2021 | 8.2 | 9.1 | 5.4 |
13 | 25–30 June 2021 | 25.1 | 30.7 | 7.8 |
14 | 30 July–4 August 2021 | 50.0 | 58.3 | 23.8. |
15 | 27 August–1 September 2021 | 64.2 | 72.3 | 39.5 |
Dates | Before (1) | After (2) | Difference (2)–(1) |
---|---|---|---|
STAYING INDOORS | 2.96 | 3.11 | 0.14 *** (0.10–0.18) |
NOT GOING TO WORK | 3.03 | 3.22 | 0.19 *** (0.13–0.24) |
NOT FOR LEISURE | 4.21 | 4.32 | 0.10 *** (0.07–0.14) |
HANDWASHING | 4.19 | 4.36 | 0.16 *** (0.13–0.19) |
WEARING MASK | 4.45 | 4.75 | 0.29 *** (0.26–0.32) |
3.1. Full Sample Estimations
(1) STAYING INDOORS | (2) NOT GOING TO WORK | (3) NOT FOR LEISURE | (4) HANDWASHING | (5) WEARING MASK | |
---|---|---|---|---|---|
VACCINE FIRST | 0.057 ** (0.007–0.106) | 0.032 (−0.016–0.080) | 0.027 (−0.014–0.069) | 0.026 * (−0.001–0.054) | −0.001 (−0.047–0.045) |
VACCINE SECOND_1 | 0.099 *** (0.058–0.140) | 0.070 ** (0.007–0.132) | 0.077 *** (0.031–0.122) | 0.006 (−0.029–0.041) | −0.006 (−0.046–0.034) |
VACCINE SECOND_2 | 0.123 *** (0.061–0.187) | 0.123 *** (0.042–0.204) | 0.106 *** (0.047–0.165) | −0.012 (−0.051–0.027) | −0.0003 (−0.048–0.047) |
VACCINE SECOND_3 | 0.097 (−0.023–0.217) | 0.092 (−0.020–0.206) | 0.018 (−0.097–0.133) | 0.035 (−0.023–0.095) | −0.027 (−0.094–0.040) |
VACCINE SECOND_4 | 0.014 (−0.335–0.365) | −0.019 (−0.167–0.128) | −0.106 (−0.341–0.128) | −0.018 (−0.142–0.105) | −0.040 (−0.177–0.095) |
PROBABILITY COVID19 | −0.291 (−1.064–0.480) | −0.532 (−1.657–0.591) | 0.103 (−0.328–0.535) | 0.428 * (−0.079–0.936) | −0.472 (−1.208–0.263) |
SEVERITY COVID19 | 0.016 *** (0.007–0.026) | 0.017 * (−0.001–0.036) | 0.036 *** (0.019–0.053) | 0.018 *** (0.006–0.030) | 0.033 *** (0.021–0.045) |
EMERGENCY | 0.022 (−0.008–0.054) | 0.034 ** (0.007–0.062) | 0.047 *** (0.017–0.078) | −0.001 (−0.016–0.014) | 0.013 (−0.002–0.020) |
ANGER | 0.035 *** (0.025–0.046) | 0.023 *** (0.007–0.039) | 0.054 *** (0.038–0.069) | 0.018 *** (0.009–0.027) | 0.009 (−0.002–0.020) |
FEAR | 0.051 *** (0.035–0.066) | 0.031 *** (0.009–0.053) | 0.045 *** (0.024–0.067) | 0.018 *** (0.007–0.028) | 0.036 *** (0.021–0.052) |
ANXIETY | 0.037 *** (0.023–0.051) | 0.021 * (−0.001–0.044) | 0.049 *** (0.034–0.063) | 0.026 *** (0.015–0.036) | 0.029 *** (0.012–0.047) |
WAVE 1 | <Default> | ||||
WAVE 2 | 0.126 *** (0.085–0.167) | 0.092 *** (0.048–0.137) | 0.170 *** (0.113–0.226) | 0.043 ** (0.009–0.077) | 0.047 *** (0.016–0.079) |
WAVE 3 | 0.446 *** (0.355–0.536) | 0.273 *** (0.181–0.365) | 0.516 *** (0.450–0.582) | 0.177 *** (0.144–0.210) | 0.386 *** (0.332–0.440) |
WAVE 4 | 0.829 *** (0.738–0.920) | 0.687 *** (0.592–0.782) | 0.698 *** (0.622–0.773) | 0.329 *** (0.286–0.373) | 0.833 *** (0.755–0.915) |
WAVE 5 | 0.435 *** (0.353–0.517) | 0.269 *** (0.185–0.354) | 0.517 *** (0.456–0.577) | 0.289 *** (0.260–0.318) | 0.862 *** (0.802–0.924) |
WAVE 6 | 0.052 (−0.014–0.119) | −0.010 (−0.082–0.060) | 0.025 (−0.038–0.090) | 0.237 *** (0.203–0.272) | 1.010 (0.942–1.079) |
WAVE 7 | 0.161 *** (0.101–0.221) | 0.017 (−0.046–0.081) | 0.157 *** (0.108–0.206) | 0.267 *** (0.235–0.300) | 1.061 *** (0.993–1.130) |
WAVE 8 | 0.389 *** (0.307–0.470) | 0.141 *** (0.061–0.220) | 0.458 *** (0.391–0.525) | 0.317 *** (0.278–0.356) | 1.122 *** (1.040–1.204) |
WAVE 9 | 0.368 *** (0.306–0.431) | 0.153 *** (0.095–0.210) | 0.417 *** (0.0357–0.477) | 0.319 *** (0.274–0.365) | 1.146 *** (1.068–1.224) |
WAVE 10 | 0.344 *** (0.271–0.416) | 0.140 *** (0.070–0.210) | 0.323 *** (0.259–0.387) | 0.339 *** (0.305–0.374) | 1.133 *** (1.065–1.201) |
WAVE 11 | 0.304 *** (0.239–0.369) | 0.132 *** (0.071–0.192) | 0.373 *** (0.309–0.436) | 0.336 *** (0.300–0.372) | 1.126 *** (1.053–1.198) |
WAVE 12 | 0.375 *** (0.304–0.446) | 0.195 *** (0.132–0.259) | 0.442 *** (0.375–0509) | 0.363 *** (0.322–0.405) | 1.139 *** (1.064–1.213) |
WAVE 13 | 0.309 *** (0.233–0.385) | 0.141 *** (0.079–0.201) | 0.365 *** (0.206–0.350) | 0.372 *** (0.334–0.410) | 1.132 *** (1.059–1.206) |
WAVE 14 | 0.282 *** (0.207–0.357) | 0.156 *** (0.078–0.232) | 0.278 *** (0.206–0.350) | 0.355 *** (0.315–0.395) | 1.111 *** (1.036–1.185) |
WAVE 15 | 0.346 *** (0.248–0.444) | 0.231 *** (0.141–0.322) | 0.384 *** (0.299–0.469) | 0.413 *** (0.360–0.467) | 1.135 *** (1.051–1.219) |
Adj R2 Obs. | 0.37 54,007 | 0.65 54,007 | 0.37 54,007 | 0.62 54,007 | 0.49 54,007 |
(1) STAYING INDOORS | (2) NOT GOING TO WORK | (3) NOT FOR LEISURE | (4) HANDWASHING | (5) WEARING MASK | |
---|---|---|---|---|---|
VACCINE FIRST | 0.057 ** (0.007–1.077) | 0.032 (−0.015–0.080) | 0.028 (−0.014–0.069) | 0.028 ** (0.0003–0.057) | 0.003 (−0.044–0.050) |
VACCINE SECOND | 0.107 *** (0.059–0.154) | 0.090 *** (0.028–0.152) | 0.079 *** (0.0355–0.123) | 0.008 (−0.024–0.041) | 0.005 (−0.038–0.048) |
Adj R2 Obs. | 0.52 54,007 | 0.66 54,007 | 0.37 54,007 | 0.62 54,007 | 0.49 54,007 |
(1) STAYING INDOORS | (2) NOT GOING TO WORK | (3) NOT FOR LEISURE | (4) HANDWASHING | (5) WEARING MASK | |
---|---|---|---|---|---|
VACCINE FIRST | |||||
(Prob[y = 1]) | −0.019 ** (−0.036–−0.003) | −0.016 (−0.047–0.014) | −0.003 (−0.011–0.004) | −0.003 ** (−0.006–−0.001) | −0.009 * (−0.019–0.0004) |
(Prob[y = 2) | −0.010 ** (−0.019–−0.001) | −0.017 (−0.004–−0.001) | −0.002 (−0.006–0.002) | −0.007 ** (−0.013–−0.001) | −0.006 * (−0.014–0.0003) |
(Prob[y = 3) | −0.0007 ** (−0.001–−0.0001) | 0.0004 (−0.0003–0.001) | −0.007 (−0.024–0.009) | −0.022 ** (−0.041–−0.003) | −0.014 * (−0.029–0.0006) |
(Prob[y = 4) | 0.019 ** (0.003–0.036) | 0.002 (−0.001–0.005) | −0.002 (−0.005–0.002) | −0.006 ** (−0.012–−0.001) | −0.015 * (−0.032–0.007) |
(Prob[y = 5) | 0.011 ** (0.001–0.021) | 0.011 (−0.013–0.046) | 0.015 (−0.018–0.049) | 0.004 ** (0.007–0.073) | 0.047 * (−0.002–0.096) |
VACCINE SECOND | |||||
(Prob[y = 1]) | −0.036 *** (−0.054–−0.018) | −0.050 *** (−0.084–−0.015) | −0.012 *** (−0.020–−0.004) | −0.002 (−0.005–0.001) | −0.014 *** (−0.023–−0.004) |
(Prob[y = 2) | −0.019 *** (−0.029–−0.009) | −0.005 *** (−0.008–−0.001) | −0.007 *** (−0.011–−0.002) | −0.004 (−0.010–0.001) | −0.010 *** (−0.017–−0.003) |
(Prob[y = 3) | −0.001 *** (−0.002–−0.0006) | 0.001 *** (0.0003–0.002) | −0.027 *** (−0.043–−0.010) | −0.013 (−0.032–0.005) | −0.021 *** (−0.035–−0.006) |
(Prob[y = 4) | 0.036 *** (0.018–0.053) | 0.005 *** (0.001–0.009) | −0.006 *** (−0.010–0.002) | −0.004 (−0.009–0.002) | −0.023 *** (−0.039–0.006) |
(Prob[y = 5) | 0.021 *** (0.010–0.031) | 0.048 *** (0.015–0.081) | 0.053 *** (0.020–0.086) | 0.023 (−0.010–0.057) | 0.068 *** (0.020–0.115) |
Wald-chi 2 Obs. | 2551 54,007 | 1269 54,007 | 2340 54,007 | 1232 54,007 | 3426 54,007 |
3.2. Subsample Estimations (Young vs. Old Ages Groups)
(1) STAYING INDOORS | (2) NOT GOING TO WORK | (3) NOT FOR LEISURE | (4) HANDWASHING | (5) WEARING MASK | |
---|---|---|---|---|---|
VACCINE FIRST | −0.095 (−0.127–0.108) | −0.037 (−0.167–0.092) | −0.025 (−0.143–0.093) | −0.031 (−0.056–0.092) | 0.017 (−0.053–0.027) |
VACCINE SECOND_1 | −0.106 (−0274–0.60) | −0.249 *** (−0.386–−0.111) | 0.049 (−0.083–0.187) | −0.060 (−0.068–0.111) | 0.021 (−0.059–0.025) |
VACCINE SECOND_2 | −0.283 ** (−0.556–−0.010) | −0.392 ** (−0.594–−0.191) | 0.029 (−0.210–0.269) | 0.0002 (−0.069–0.176) | 0.053 (−0.074–0.031) |
VACCINE SECOND_3 | −0.288 * (−0.600–0.022) | −0.347 * (−0.713–0.017) | −0.079 (−0.337–0.179) | −0.053 (−0.129–0.413) | 0.142 (−0.101–0.013) |
VACCINE SECOND_4 | −0.467 (−1.086–0.151) | −0.615 *** (−0.875–−0.355) | −0.140 (−0.740–0.458) | 0.004 (−0.116–0.245) | 0.064 (−0.243–0.088) |
Adj R2 Obs. | 0.49 15,407 | 0.56 15,407 | 0.37 15,407 | 0.52 15,407 | 0.58 15,407 |
(1) STAYING INDOORS | (2) NOT GOING TO WORK | (3) NOT FOR LEISURE | (4) HANDWASHING | (5) WEARING MASK | |
---|---|---|---|---|---|
VACCINE FIRST | 0.036 (−0.022–0.095) | 0.026 (−0.034–0.086) | 0.013 (−0.030–0.056) | 0.024 * (−0.003–0.051) | −0.012 (−0.003–0.051) |
VACCINE SECOND_1 | 0.089 *** (0.036–0.143) | 0.105 ** (0.040–0.170) | 0.051 * (−0.001–0.103) | −0.001 (−0.046–0.043) | −0.016 (−0.046–0.043) |
VACCINE SECOND_2 | 0.120 *** (0.053–0.187) | 0.175 *** (0.097–0.252) | 0.084 *** (0.023–0.144) | −0.024 (−0.074–0.025) | −0.021 (−0.074–0.025) |
VACCINE SECOND_3 | 0.118 * (− 0.002–0.239) | 0.170 *** (0.058–0.282) | 0.005 (− 0.123–0.135) | 0.012 (−0.052–0.078) | −0.043 (−0.052–0.078) |
VACCINE SECOND_4 | 0.131 (−0.219–0.481) | 0.167 * (−0.024–0.358) | −0.123 (−0.384–0.136) | −0.048 (−0.211–0.115) | −0.077 (−0.211–0.115) |
Adj R2 Obs. | 0.52 38,600 | 0.68 38,600 | 0.35 38,600 | 0.63 38,600 | 0.53 38,600 |
4. Discussion
4.1. Strength
4.2. Limitation
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Born, B.; Dietrich, A.M.; Müller, G.J. The Lockdown Effect: A Counterfactual for Sweden. PLoS ONE 2021, 16, e0249732. [Google Scholar] [CrossRef] [PubMed]
- Tian, H.; Liu, Y.; Li, Y.; Wu, C.-H.; Chen, B. Kraemer MUG An Investigation of Transmission Control Measures during the First 50 Days of the COVID-19 Epidemic in China. Science 2020, 368, 638–642. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Imperial College COVID-19 Response Team; Flaxman, S.; Mishra, S.; Gandy, A.; Unwin, H.J.T.; Mellan, T.A. Estimating the Effects of Non-Pharmaceutical Interventions on COVID-19 in Europe. Nature 2020, 584, 257–261. [Google Scholar] [CrossRef] [PubMed]
- Hyafil, A.; Moriña, D. Analysis of the Impact of Lockdown on the Reproduction Number of the SARS-CoV-2 in Spain. Gac. Sanit. 2021, 35, 453–458. [Google Scholar] [CrossRef]
- Alfano, V.; Ercolano, S. The Efficacy of Lockdown Against COVID-19: A Cross-Country Panel Analysis. Appl. Health Econ. Health Policy 2020, 18, 509–517. [Google Scholar] [CrossRef] [PubMed]
- Ambikapathy, B.; Krishnamurthy, K. Mathematical Modelling to Assess the Impact of Lockdown on COVID-19 Transmission in India: Model Development and Validation. JMIR Public Health Surveill 2020, 6, e19368. [Google Scholar] [CrossRef]
- Mottaleb, K.A.; Mainuddin, M.; Sonobe, T. COVID-19 Induced Economic Loss and Ensuring Food Security for Vulnerable Groups: Policy Implications from Bangladesh. PLoS ONE 2020, 15, e0240709. [Google Scholar] [CrossRef]
- Inoue, H.; Murase, Y.; Todo, Y. Do Economic Effects of the Anti-COVID-19 Lockdowns in Different Regions Interact through Supply Chains? PLoS ONE 2021, 16, e0255031. [Google Scholar] [CrossRef]
- Chinna, K.; Sundarasen, S.; Khoshaim, H.B.; Kamaludin, K.; Nurunnabi, M.; Baloch, G.M.; Hossain, S.F.A.; Sukayt, A.; Dalina, N.; Rajagopalan, U.; et al. Psychological Impact of COVID-19 and Lock down Measures: An Online Cross-Sectional Multicounty Study on Asian University Students. PLoS ONE 2021, 16, e0253059. [Google Scholar] [CrossRef]
- Fiorenzato, E.; Zabberoni, S.; Costa, A.; Cona, G. Cognitive and Mental Health Changes and Their Vulnerability Factors Related to COVID-19 Lockdown in Italy. PLoS ONE 2021, 16, e0246204. [Google Scholar] [CrossRef]
- Greyling, T.; Rossouw, S.; Adhikari, T. The Good, the Bad and the Ugly of Lockdowns during COVID-19. PLoS ONE 2021, 16, e0245546. [Google Scholar] [CrossRef]
- Ogden, R. Distortions to the Passage of Time during England’s Second National Lockdown: A Role for Depression. PLoS ONE 2021, 16, e0250412. [Google Scholar] [CrossRef]
- Yamamura, E.; Tsutsui, Y. Impact of the State of Emergency Declaration for COVID-19 on Preventive Behaviours and Mental Conditions in Japan: Difference in Difference Analysis Using Panel Data. COVID Econ. Vetted Real-Time Pap. 2020, 23, 303–324. [Google Scholar]
- WHO Coronavirus (COVID-19) Dashboard WHO Coronavirus Disease (COVID-19). 10 August 2021.
- Perez-Arce, F.; Angrisani, M.; Bennett, D.; Darling, J.; Kapteyn, A.; Thomas, K. COVID-19 Vaccines and Mental Distress. PLoS ONE 2021, 16, e0256406. [Google Scholar] [CrossRef]
- Pandey, K.; Thurman, M.; Johnson, S.D.; Acharya, A.; Johnston, M.; Klug, E.A.; Olwenyi, O.A.; Rajaiah, R.; Byrareddy, S.N. Mental Health Issues During and After COVID-19 Vaccine Era. Brain Res. Bull. 2021, 176, 161–173. [Google Scholar] [CrossRef]
- Yuan, Y.; Deng, Z.; Chen, M.; Yin, D.; Zheng, J.; Liu, Y.; Liu, X.; Zou, H.; Zhang, C.; Sun, C. Changes in Mental Health and Preventive Behaviors before and after COVID-19 Vaccination: A Propensity Score Matching (PSM) Study. Vaccines 2021, 9, 1044. [Google Scholar] [CrossRef]
- Japan Times. Japan Gives First COVID-19 Vaccines to Health Workers. Japan Times, 26 February 2021. [Google Scholar]
- Mantzari, E.; Rubin, G.J.; Marteau, T.M. Is Risk Compensation Threatening Public Health in the Covid19 Pandemic? BMJ 2020, 370, m2913. [Google Scholar] [CrossRef]
- Ioannidis, J.P.A. Benefit of COVID-19 Vaccination Accounting for Potential Risk Compensation. NPJ Vaccines 2021, 6, 99. [Google Scholar] [CrossRef]
- Trogen, B.; Caplan, A. Risk Compensation and COVID-19 Vaccines. Ann. Intern. Med. 2021, 174, 858–859. [Google Scholar] [CrossRef]
- Rubin, G.J.; Brainard, J.; Hunter, P.; Michie, S. Are People Letting down Their Guard Too Soon after COVID-19 Vaccination? BMJ Opinion, 18 March 2021. [Google Scholar]
- Morikawa, M. COVID-19, Vaccination, and Consumper Behavior; RIETI: Tokyo, Japan, 2021. [Google Scholar]
- Sunohara, S.; Asakura, T.; Kimura, T.; Ozawa, S.; Oshima, S.; Yamauchi, D.; Tamakoshi, A. Effective Vaccine Allocation Strategies, Balancing Economy with Infection Control against COVID-19 in Japan. PLoS ONE 2021, 16, e0257107. [Google Scholar] [CrossRef]
- Zhang, N.; Liu, X.; Jin, T.; Zhao, P.; Miao, D.; Lei, H.; Su, B.; Xue, P.; Xie, J.; Li, Y. Weakening Personal Protective Behavior by Chinese University Students after COVID-19 Vaccination. Build Environ. 2021, 206, 108367. [Google Scholar] [CrossRef] [PubMed]
- Hossain, M.E.; Islam, M.S.; Rana, M.J.; Amin, M.R.; Rokonuzzaman, M.; Chakrobortty, S.; Saha, S.M. Scaling the Changes in Lifestyle, Attitude, and Behavioral Patterns among COVID-19 Vaccinated People: Insights from Bangladesh. Hum. Vaccines Immunother. 2022, 18, 2022920. [Google Scholar] [CrossRef] [PubMed]
- Zhang, N.; Lei, H.; Li, L.; Jin, T.; Liu, X.; Miao, D.; Su, B.; Bu, Z.; Fan, L.; Xue, P.; et al. COVID-19 Vaccination Did Not Change the Personal Protective Behaviors of Healthcare Workers in China. Front. Public Health 2021, 9, 777426. [Google Scholar] [CrossRef] [PubMed]
- Wright, L.; Steptoe, A.; Mak, H.W.; Fancourt, D. Do People Reduce Compliance with COVID-19 Guidelines Following Vaccination? A Longitudinal Analysis of Matched UK Adults. J. Epidemiol. Community Health 2022, 76, 109–115. [Google Scholar] [CrossRef]
- Wooldridge, J. Introductory Econometrics, 4th ed.; South-Western Cengage Learning: New York, NY, USA, 2009. [Google Scholar]
- Hsiao, C. Aalysis of Panel Data; Cambridge University Press: New York, NY, USA, 1986. [Google Scholar]
- Baltagi, B. Econometric Analysis of Panel Data; John Wiley & Sons: New York, NY, USA, 1995. [Google Scholar]
- Nagasu, M.; Yamamoto, I. Impact of Socioeconomic- And Lifestyle-Related Risk Factors on Poor Mental Health Conditions: A Nationwide Longitudinal 5-Wave Panel Study in Japan. PLoS ONE 2020, 15, e0240240. [Google Scholar] [CrossRef]
- Wooldridge, J. Econometric Analysis of Cross Section and Panel Data; MIT Press: Cambridge, UK, 2002. [Google Scholar]
- Greene, W. Econometric Analysis, 6th ed.; Pearson, Preantice Hall: New York, NY, USA, 2008. [Google Scholar]
- Yamamura, E.; Tsutsui, Y. The Impact of Closing Schools on Working from Home during the COVID-19 Pandemic: Evidence Using Panel Data from Japan. Rev. Econ. Househ. 2021, 19, 41–60. [Google Scholar] [CrossRef] [PubMed]
- Rosenstock, I. The Health Belief Model and Preventive Behavior. Health Educ. Behav. 1974, 2, 27–59. [Google Scholar] [CrossRef]
- Rosenstock, I.; Strecher, V.; Becker, M. Social Learning Theory and the Health Belief Model. Health Educ. Behav. 1988, 15, 175–183. [Google Scholar] [CrossRef]
- Asri, A.; Asri, V.; Renerte, B.; Föllmi-Heusi, F.; Leuppi, J.D.; Muser, J.; Nüesch, R.; Schuler, D.; Fischbacher, U. Wearing a Mask-For Yourself or for Others? Behavioral Correlates of Mask Wearing among COVID-19 Frontline Workers. PLoS ONE 2021, 16, e0253621. [Google Scholar] [CrossRef]
- Travis, J.; Harris, S.; Fadel, T.; Webb, G. Identifying the Determinants of COVID-19 Preventative Behaviors and Vaccine Intentions among South Carolina Residents. PLoS ONE 2021, 16, e0256178. [Google Scholar] [CrossRef]
- Japan Times. 75% of Japan’s Older Residents Have Received First COVID-19 Vaccine Shot. Japan Times, 11 July 2021. [Google Scholar]
- Japan Times. Japan to Start COVID-19 Vaccinations at Workplaces and Universities on June 21. Japan Times, 22 June 2021. [Google Scholar]
- Department of Medical Genome Sciences, R.I. for F.M.S.M.U.S. of M.JAPAN. Transition of COVID-19 Vaccination Rates by Country. Available online: https://web.sapmed.ac.jp/canmol/coronavirus/vaccine_e.html?a=1&f=y&c=1&s=y (accessed on 20 August 2021).
- Rose, G. The Determinants of Individual Cases Sick Individuals and Sick Populations. Int. J. Epidemiol. 2001, 30, 427–432. [Google Scholar] [CrossRef] [Green Version]
- Cheng, K.K.; Lam, T.H.; Leung, C.C. Wearing Face Masks in the Community during the COVID-19 Pandemic: Altruism and Solidarity. Lancet 2020, 399, e39–e40. [Google Scholar] [CrossRef]
- Powdthavee, N.; Riyanto, Y.E.; Wong, E.C.L.; Yeo, J.X.W.; Chan, Q.Y. When Face Masks Signal Social Identity: Explaining the Deep Face-Mask Divide during the COVID-19 Pandemic. PLoS ONE 2021, 16, e0253195. [Google Scholar] [CrossRef]
- Weisel, O. Vaccination as a social contract:The case of COVID-19 and US Political Partisanship. Proc. Natl. Acad. Sci. USA 2021, 118, e2026745118. [Google Scholar] [CrossRef]
- Agüero, J.; Beleche, T. Health Shocks and Their Long-Lasting Impact on Health Behaviors: Evidence from the 2009 H1N1 Pandemic in Mexico. J. Health Econ. 2017, 54, 45–55. [Google Scholar] [CrossRef]
- Health Experts of UNICEF. What to Do before, during and after Getting Vaccinated for COVID-19. Available online: https://www.unicef.org/coronavirus/before-during-after-COVID-19-vaccine (accessed on 20 August 2021).
- Allcott, H. Social Norms and Energy Conservation. J. Public Econ. 2011, 95, 1082–1095. [Google Scholar] [CrossRef] [Green Version]
- Allcott, H.; Knittel, C. Are Consumers Poorly Informed about Fuel Economy? Evidence from Two Experiments. Am. Econ. J. Econ. Policy 2019, 11, 1–37. [Google Scholar] [CrossRef] [Green Version]
- Sasaki, S.; Kurokawa, H.; Ohtake, F. Effective but Fragile? Responses to Repeated Nudge-Based Messages for Preventing the Spread of COVID-19 Infection. Jpn. Econ. Rev. 2021, 72, 371–408. [Google Scholar] [CrossRef]
- Zeballos Rivas, D.R.; Lopez Jaldin, M.L.; Nina Canaviri, B.; Portugal Escalante, L.F.; Alanes Fernández, A.M.C.; Aguilar Ticona, J.P. Social Media Exposure, Risk Perception, Preventive Behaviors and Attitudes during the COVID-19 Epidemic in La Paz, Bolivia: A Cross Sectional Study. PLoS ONE 2021, 16, e0245859. [Google Scholar] [CrossRef]
- Muto, K.; Yamamoto, I.; Nagasu, M.; Tanaka, M.; Wada, K. Japanese Citizens’ Behavioral Changes and Preparedness against COVID-19: An Online Survey during the Early Phase of the Pandemic. PLoS ONE 2020, 15, e0234292. [Google Scholar] [CrossRef]
- Ohtake, F.; Saito, M. Population Aging And Consumption Inequality In Japan. Rev. Income Wealth 1998, 44, 361–381. [Google Scholar] [CrossRef]
- Desrichard, O.; Moussaoui, L.; Ofosu, N. Do Vaccinated People Reduce Their Precautionary Behaviours? A Test on a British Cohort. Res. Sq. 2021. [Google Scholar] [CrossRef]
- Chan, Y.E. Moral Foundations Underlying Behavioural Compliance during the COVID-19 Pandemic. Pers. Individ. Dif. 2021, 171, 110463. [Google Scholar] [CrossRef]
- Si, R.; Yao, Y.; Zhang, X.; Lu, Q.; Aziz, N. Investigating the Links Between Vaccination Against COVID-19 and Public Attitudes Toward Protective Countermeasures: Implications for Public Health. Front. Public Health 2021, 9, 702699. [Google Scholar] [CrossRef] [PubMed]
- Korn, L.; Böhm, R.; Meier, N.W.; Betsch, C. Vaccination as a Social Contract. Proc. Natl. Acad. Sci. USA 2020, 117, 14890–14899. [Google Scholar] [CrossRef] [PubMed]
- Liu, Q.; An, Z.; Liu, Y.; Ying, W.; Zhao, P. Smartphone-Based Services, Perceived Accessibility, and Transport Inequity during the COVID-19 Pandemic: A Cross-Lagged Panel Study. Transp. Res. D Transp. Environ. 2021, 97, 102914. [Google Scholar] [CrossRef]
- Duan, Y.; Lippke, S.; Liang, W.; Shang, B.; Keller, F.M.; Wagner, P.; Baker, J.S.; He, J. Association of Social-Cognitive Factors with Individual Preventive Behaviors of COVID-19 among a Mixed-Sample of Older Adults from China and Germany. Int. J. Environ. Res. Public Health 2022, 19, 6364. [Google Scholar] [CrossRef]
- Li, F.; Liang, W.; Rhodes, R.E.; Duan, Y.; Wang, X.; Shang, B.; Yang, Y.; Jiao, J.; Yang, M.; Supriya, R.; et al. A Systematic Review and Meta-Analysis on the Preventive Behaviors in Response to the COVID-19 Pandemic among Children and Adolescents. BMC Public Health 2022, 22, 1201. [Google Scholar] [CrossRef]
- Liang, W.; Duan, Y.; Li, F.; Rhodes, R.E.; Wang, X.; Peiris, D.L.I.H.K.; Zhou, L.; Shang, B.; Yang, Y.; Baker, J.S.; et al. Psychosocial Determinants of Hand Hygiene, Facemask Wearing, and Physical Distancing during the COVID-19 Pandemic: A Systematic Review and Meta-Analysis. Ann. Behav. Med. 2022, 56, 1174–1187. [Google Scholar] [CrossRef]
- Lopez Bernal, J.; Andrews, N.; Gower, C.; Gallagher, E.; Simmons, R.; Thelwall, S.; Stowe, J.; Tessier, E.; Groves, N.; Dabrera, G.; et al. Effectiveness of COVID-19 Vaccines against the B.1.617.2 (Delta) Variant. N. Engl. J. Med. 2021, 385, 585–594. [Google Scholar] [CrossRef]
- Duan, Y.; Shang, B.; Liang, W.; Lin, Z.; Hu, C.; Baker, J.S.; Wang, Y.; He, J. Predicting Hand Washing, Mask Wearing and Social Distancing Behaviors among Older Adults during the COVID-19 Pandemic: An Integrated Social Cognition Model. BMC Geriatr. 2022, 22, 91. [Google Scholar] [CrossRef]
Variables | Definition |
---|---|
Dependent variables | |
STAYING INDOORS | In the last week, how consistent were you at “not going out of home?” Please choose among five choices. 1 (not completed at all) to 5 (completely consistent). |
NOT GOING TO WORK | In the last week, how consistent were you at “not going out to work (or school)?” Please choose among five choices. 1 (not completed at all) to 5 (completely achieved). |
NOT FOR LEISURE | In the last week, how consistent were you at “not going out to events or travel?” Please choose among five choices. 1 (not completed at all) to 5 (completely achieved). |
HANDWASHING | In the last week, how consistent were you at “washing your hands?” Please choose among five choices. 1 (not completed at all) to 5 (completely achieved). |
WEARING MASK | In the last week, how consistent were you at “wearing a mask?” Please choose among five choices. 1 (not completed at all) to 5 (completely achieved). |
Confounders (Independent variables) | |
VACCINE FIRST | Did you get the first shot (but not the second one)? 1 (Yes) or 0 (No) |
VACCINE SECOND | Did you get the second shot? 1 (Yes) or 0 (No) |
VACCINE SECOND_1 | Did you get the second shot this month? 1 (Yes) or 0 (No) |
VACCINE SECOND_2 | Did you get the second shot last month? 1 (Yes) or 0 (No) |
VACCINE SECOND_3 | Did you get the second shot two months ago? 1 (Yes) or 0 (No) |
VACCINE SECOND_4 | Did you get the second shot three months ago? 1 (Yes) or 0 (No) |
PROB_COVID19 | What percentage do you think is the probability of your getting COVID-19? Please choose from 0 to 100 (%) |
SEVERITY COVID19 | How serious are your symptoms if you are infected with the novel coronavirus? Choose from 6 choices. 1 (very small influence) to 6 (death) |
EMERGENCY | Is your area in a state of emergency? 1 (Yes) or 0 (No) |
FEAR | How intense is your feeling of fear? Please answer on a scale from 1 (I have not felt this emotion at all) to 5 (I have felt this emotion strongly). |
ANXIETY | How intense is your feeling of anxiety? Please answer on a scale from 1 (I have not felt this emotion at all) to 5 (I have felt this emotion strongly). |
ANGER | How intense is your feeling of anger? Please answer on a scale from 1 (I have not felt this emotion at all) to 5 (I have felt this emotion strongly). |
AGE | Ages |
MALE | Select 1 if you are male and 0 if otherwise. |
UNIVERSITY | Select 1 if you graduated from university and 0 if otherwise. |
Waves | Obs. | Loss Rate % |
---|---|---|
1 | 4359 | 0 |
2 | 3495 | 19.8 |
3 | 4013 | 7.9 |
4 | 3996 | 8.3 |
5 | 3877 | 11.1 |
6 | 3626 | 16.8 |
7 | 3491 | 19.9 |
8 | 3509 | 19.5 |
9 | 3529 | 19.0 |
10 | 3440 | 21.1 |
11 | 3304 | 24.2 |
12 | 3280 | 24.8 |
13 | 3392 | 22.2 |
14 | 3349 | 23.2 |
15 | 3347 | 23.2 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Yamamura, E.; Kohsaka, Y.; Tsutsui, Y.; Ohtake, F. Association between the COVID-19 Vaccine and Preventive Behaviors: Panel Data Analysis from Japan. Vaccines 2023, 11, 810. https://doi.org/10.3390/vaccines11040810
Yamamura E, Kohsaka Y, Tsutsui Y, Ohtake F. Association between the COVID-19 Vaccine and Preventive Behaviors: Panel Data Analysis from Japan. Vaccines. 2023; 11(4):810. https://doi.org/10.3390/vaccines11040810
Chicago/Turabian StyleYamamura, Eiji, Youki Kohsaka, Yoshiro Tsutsui, and Fumio Ohtake. 2023. "Association between the COVID-19 Vaccine and Preventive Behaviors: Panel Data Analysis from Japan" Vaccines 11, no. 4: 810. https://doi.org/10.3390/vaccines11040810
APA StyleYamamura, E., Kohsaka, Y., Tsutsui, Y., & Ohtake, F. (2023). Association between the COVID-19 Vaccine and Preventive Behaviors: Panel Data Analysis from Japan. Vaccines, 11(4), 810. https://doi.org/10.3390/vaccines11040810